Christopher Posner, CEO of Tvardi Therapeutics TVRD, has filed 0 purchases and 13 sales on the open market. The latest trade was on 25/02/28.

CP

CP

Christopher Posner

President and CEO

Company

Tvardi Therapeutics TVRD

First filing

23/02/03

Trades

15 trades

Buys / sales

0 / 13

12-month net buying

No record

Last trade

25/02/28

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Tvardi TherapeuticsTVRD	Open-market sale	25/02/28	25/03/04	583 sh	$4.75	$2,769.25	−4.3%
Tvardi TherapeuticsTVRD	Open-market sale	25/02/04	25/02/06	372 sh	$4.72	$1,755.84	−2.6%
Tvardi TherapeuticsTVRD	Open-market sale	24/11/04	24/11/06	3,668 sh	$0.29	$1,063.72	−2.1%
Tvardi TherapeuticsTVRD	Open-market sale	24/08/01	24/08/02	4,149 sh	$0.35	$1,452.15	−2.3%
Tvardi TherapeuticsTVRD	Open-market sale	24/05/02	24/05/06	3,936 sh	$0.75	$2,952	−2.2%
Tvardi TherapeuticsTVRD	Open-market sale	24/02/29	24/03/04	5,834 sh	$0.89	$5,192.26	−3.1%
Tvardi TherapeuticsTVRD	Open-market sale	24/02/08	24/02/12	35,575 sh	$0.53	$18,854.75	−16.0%
Tvardi TherapeuticsTVRD	Open-market sale	24/02/01	24/02/05	4,981 sh	$0.55	$2,739.55	−2.2%
Tvardi TherapeuticsTVRD	Open-market sale	23/11/02	23/11/03	3,796 sh	$1.22	$4,631.12	−2.3%
Tvardi TherapeuticsTVRD	Open-market sale10b5-1 plan	23/08/03	23/08/04	4,307 sh	$3.07	$13,222.49	−2.5%
Tvardi TherapeuticsTVRD	Open-market sale10b5-1 plan	23/05/05	23/05/09	3,869 sh	$4.40	$17,023.6	−2.2%
Tvardi TherapeuticsTVRD	Open-market sale	23/03/03	23/03/07	5,987 sh	$9.71	$58,133.77	−3.3%
Tvardi TherapeuticsTVRD	Open-market sale	23/02/02	23/02/03	4,191 sh	$11.80	$49,453.8	−2.2%